The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756

By afschroeder • September 23, 2025

Rubin SA. The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756. Open Forum Infect Dis. 2025 Aug 21;12(9):ofaf480. doi: 10.1093/ofid/ofaf480. PMID: 40980592; PMCID: PMC12449218.

Tags: Cardiology/Epi, Publications, Veterans Administration

Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology State-of-the-Art Review

Morad TT, Keykhaei M, Terraciano DA, Srivastava PK, Yang EH, Stein-Merlob AF. Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology[...]

Interrelationships Between Kansas City Cardiomyopathy Questionnaire Domains, Age, and Sex for Patients With Heart Failure: Findings From the CHAMP-HF and CORC Registries

Girard AA, Jones PG, Fu Z, Sherrod CF 4th, Cantu Martinez O, Greene SJ, Bachmann JM, Fonarow GC, Butler J, Spertus JA, Arnold SV. Interrelationships[...]

Patient-Level Perivascular Adipose Tissue Density Aggregation and Plaque Progression: Plaque-Free vs Plaque-Adjacent Segments

Lee SE, Sung JM, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Chun EJ, Conte E, Gottlieb I, Hadamitzky M, Kim[...]